Xoma | XOMA - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 33.53B 4.47B 2026-03
Agenus USD 95.28M 38.15M 2026-03
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Ardelyx USD 381.87M 447K 2026-03
aTyr Pharma USD 67.58M 178.23M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Celldex Therapeutics USD 459.22M 75.44M 2026-03
Curis USD 6.92M 7.5M 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Incyte USD 5.48B 460.36M 2026-03
MacroGenics USD 182.52M 37.42M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 42.82B 76M 2026-03
Prothena USD 339.2M 24.01M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Xoma USD 110.71M 5.78M 2025-09